...
首页> 外文期刊>The Journal of extra-corporeal technology >Improved outcomes during cardiac surgery: a multifactorial enhancement of cardiopulmonary bypass techniques.
【24h】

Improved outcomes during cardiac surgery: a multifactorial enhancement of cardiopulmonary bypass techniques.

机译:心脏手术过程中改善的结果:心肺旁路技术的多因素增强。

获取原文
获取原文并翻译 | 示例
           

摘要

Patients presenting for cardiac surgery with cardiopulmonary bypass (CPB) are more likely to have pre-existing comorbidities, which has resulted in a steady increase in the risk associated with CPB. The resulting challenge has mandated the optimization of perfusion care. The purpose of this study was to retrospectively evaluate the impact of a number of simultaneous, evidence based perfusion care changes on patient outcome. After Institutional Review Board approval, two groups of patients were compared. The control group (n = 317) included all patients undergoing CPB in a 12-month period preceding a multifaceted change in perfusion techniques. The treatment group (n = 259) included all patients undergoing CPB in the 12-month period after the changes, which included the incorporation of updated continuous blood gas monitoring, biocompatible circuitry, updated centrifugal blood propulsion, continuous autotransfusion technology, new generation myocardial protection instrumentation, plasmapheresis, topicalplatelet gel application, excluding hetastarch while increasing the use of albumin, viscoelastographic coagulation monitoring, and implementing a quantitative quality improvement program. After univariate analysis, propensity scoring and multiple conditional logistical regression were used to control for demographic, preoperative, operative, and postoperative parameters. Results of the primary endpoints revealed a lower mortality rate in the treatment group (4% vs. 9% [95% confidence interval 1.33, 7.72], p = 0.009), lower transfusion rate (51% vs. 59% [1.00, 2.11], p = 0.048), and lower complication rate (55% vs. 65% [1.06,2.19], p = 0.025) despite having similar predicted mortality (11 [2,22] vs. 11[3,22], p = NS) and other preoperative and operative parameters. The lower mortality rate was concurrent with a trend towards a lower incidence of complications, consistent with the differences in primary outcomes. In conclusion, the patients treated after the implementation of a multifactorial improvement plan using evidence based changes in CPB care had decreased complication and mortality rates.
机译:进行心脏外科手术并进行体外循环(CPB)的患者更容易患有合并症,这导致与CPB相关的风险不断增加。由此产生的挑战已要求优化灌注护理。这项研究的目的是回顾性评估许多同时进行的循证灌注治疗改变对患者预后的影响。在机构审查委员会批准后,对两组患者进行了比较。对照组(n = 317)包括所有在12个月期间接受CPB的患者,这些患者在灌注技术发生了多方面的变化之前。治疗组(n = 259)包括所有在变化后的12个月内接受CPB的患者,包括合并更新的连续血气监测,生物相容性电路,更新的离心血液推进,连续自体输血技术,新一代心肌保护仪器,血浆置换术,局部血小板凝胶应用(不包括hetastarch),同时增加了白蛋白的使用,粘弹性图凝血监测以及实施定量质量改进计划。单因素分析后,倾向评分和多条件后勤回归用于控制人口统计学,术前,术中和术后参数。主要终点结果显示,治疗组的死亡率较低(4%vs. 9%[95%置信区间1.33,7.72],p = 0.009),输血率较低(51%vs. 59%[1.00,2.11] ],p = 0.048)和较低的并发症发生率(55%比65%[1.06,2.19],p = 0.025),尽管预测死亡率相似(11 [2,22] vs. 11 [3,22],p = NS)和其他术前和手术参数。较低的死亡率是同时发生并发症的趋势,这与主要结果的差异一致。总之,在实施多因素改善计划后,使用基于证据的CPB护理改变来治疗的患者减少了并发症和死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号